As per provisional closing data, the barometer index, the S&P BSE Sensex, was up 357.59 points or 0.52% to 69,653.73. The Nifty 50 index added 82.60 points or 0.40% to 20,937.70.
The Reserve Bank of India (RBI)'s six-member Monetary Policy Committee is scheduled to meet this week during 6-8 December 2023. RBI Governor Shaktikanta Das will announce the MPC decision on Friday, 8 December 2023, the last date of the meeting.
The Sensex and Nifty clocked an all-time high of 69,744.62 and 20,961.95 in late trade. Further, the Nifty Bank index also registered its fresh record high of 47,259.85.
In seven consecutive sessions, the Sensex rallied 5.58% while the Nifty climbed 5.77%.
In the broader market, the S&P BSE Mid-Cap index rose 0.19% while the S&P BSE Small-Cap index gained 0.18%.
The market breadth was positive. On the BSE, 1,929 shares rose, and 1,824 shares fell. A total of 142 shares were unchanged.
Stocks in Spotlight:
Angel One surged 7.07% after the brokerage company?s client base jumped 51.3% to 18.45 million in November 2023 as against 12.19 million in November 2022.
State Bank of India (SBI) fell 0.12%. The executive committee of the central board (ECCB) of the bank has accorded final approval for acquiring 20% stake held by SBI Capital Markets (SBICAPS) in SBI Pension Funds (SBIPFPL) by SBI. The cost of acquisition is Rs 229.52 crore.
Power Grid Corporation of India added 1.08%. The company has been declared as successful bidder under Tariff Based Competitive Bidding to establish Inter-State Transmission System Project for ?Transmission system for evacuation of additional 7 GW of RE power from Khavda RE park under Phase III Part B? on Build, Own Operate and Transfer (BOOT) basis.
Bank of India rallied 6.13%. The public sector bank announced that its board has approved the opening of qualified institutional placement (QIP) of equity shares with the floor price of Rs 105.42 per share.
Lupin fell 0.87%. The pharma major announced that it has received approval from US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) of Varenicline tablets. The approved durg is generic equivalent of Chantix tablets of PF Prism C.V. It is indicated for use as an aid to smoking cessation treatment.
Zydus Lifesciences rose 0.25%. The drug major announced that it has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Methylene Blue injection.
Himadri Speciality Chemical jumped 4.27% after the company?s board approved to set up manufacturing facility for the production of Lithium-ion Battery (LiB) components with annual capacity of 200,000 MT through subsidiaries.
Greenpanel Industries declined 1.24% after the company informed that operations at MDF plant located at Chittor, Andhra Pradesh, has been disrupted due to Cyclone Michaung.
Global markets:
European stocks advanced while Asian stocks traded mixed on Wednesday, bolstered by the uptick in US high-tech shares amidst evaluations of US labour market data indicating a slowdown.
Meanwhile, Moody?s Investors Service downgraded its outlook for Chinese sovereign bonds to ?negative,? highlighting global worries over the country?s soaring debt. While maintaining an A1 long-term rating, Moody?s expressed concerns about China?s heavy reliance on fiscal stimulus for local entities and state-owned firms, posing economic risks.
Wall Street finished mixed on Tuesday after fresh employment data bolstered bets that the U.S. Federal Reserve will cut interest rates as soon as March.
Powered by Capital Market - Live News